Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bacterial Infections and Mycoses
  Free Subscription

Articles published in
Am J Respir Crit Care Med
    October 2026
  1. LIU K, Chen B, Li T, Zheng A, et al
    Serial Mass Tuberculosis Screening Among the Elderly in Eastern China from 2021-2023.
    Am J Respir Crit Care Med. 2026 Oct 20:aamag564. doi: 10.1093.
    >> Share

    September 2026
  2. MENDELSOHN SC, Andrade BB, Araujo-Pereira M, Amorim GC, et al
    Blood transcriptomic signatures predict poor outcomes in drug-susceptible pulmonary tuberculosis in Brazil.
    Am J Respir Crit Care Med. 2026;212:2211-2225.
    >> Share

    August 2026
  3. JING TEO AK, Nguyen TV, MacLean EL, Nguyen TA, et al
    Asymptomatic tuberculosis: new insights and knowledge gaps.
    Am J Respir Crit Care Med. 2026 Aug 22:aamag444. doi: 10.1093.
    >> Share

  4. MCNAIR E, Valawalkar S, Cox S, Mave V, et al
    Reply to Liang et al.: Interpreting Post-Tuberculosis Lung Disease after Extrapulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2026 Aug 12:aamag425. doi: 10.1093.
    >> Share

  5. LIANG M, He J, Qu J
    Interpreting Post-Tuberculosis Lung Disease after Extrapulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2026 Aug 12:aamag424. doi: 10.1093.
    >> Share

    July 2026
  6. DENNING DW, Rogers TR, Takazono T, Su X, et al
    Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.
    Am J Respir Crit Care Med. 2026 Jul 1:aamag310. doi: 10.1093.
    >> Share

    June 2026
  7. KURBATOVA EV
    Host-Response Biomarkers in Tuberculosis: Emerging Tools for Treatment Monitoring and Outcome Prediction.
    Am J Respir Crit Care Med. 2026 Jun 5:aamag279. doi: 10.1093.
    >> Share

    May 2026
  8. MCNAIR E, Valawalkar S, Cox SR, Kadam A, et al
    Post-Tuberculosis Lung Disease in Treated Extra-Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2026 May 13:aamag107. doi: 10.1093.
    >> Share

    April 2026
  9. GANDHI NR, Naidoo K, Lutchminarain K, Omar SV, et al
    Role of Casual Contact in Drug-Resistant Tuberculosis Transmission: A Molecular Epidemiology Study.
    Am J Respir Crit Care Med. 2026 Apr 28:aamag140. doi: 10.1093.
    >> Share

  10. ANTHONY RM
    Casual and close social contacts are important; also for tuberculosis.
    Am J Respir Crit Care Med. 2026 Apr 28:aamag204. doi: 10.1093.
    >> Share

    March 2026
  11. DELEGER JN, Khatami SN, Jones M, Jalali MS, et al
    Cost-Effectiveness of Community Tuberculosis Screening in South Africa.
    Am J Respir Crit Care Med. 2026 Mar 30:aamag163. doi: 10.1093.
    >> Share

  12. DOURNES G, Benlala I, Blanchard E
    Bronchial dilation versus bronchiectasis - lessons learned from Influenza-associated pulmonary aspergillosis.
    Am J Respir Crit Care Med. 2026 Mar 22:aamag059. doi: 10.1093.
    >> Share

  13. SAKAI C, Nonaka M, Matsuyama M, Matsumura S, et al
    Transcriptomic profiling in Mycobacterium avium complex pulmonary disease identifies clusters linked to disease severity and neutrophil activation.
    Am J Respir Crit Care Med. 2026;212:625-641.
    >> Share

    February 2026
  14. ZIFODYA JS, Kijaro LA, Nduba V, Khatun S MS, et al
    Clinical and transcriptomic risk factors for post-tuberculosis lung disease in a cohort of Kenyan adults.
    Am J Respir Crit Care Med. 2026 Feb 21:aamag063. doi: 10.1093.
    >> Share

  15. WIEDER C, Horswell S, Kelly G, Stek C, et al
    Novel genetic variants in tuberculosis-associated immune reconstitution inflammatory syndrome.
    Am J Respir Crit Care Med. 2026 Feb 10:aamag037. doi: 10.1093.
    >> Share

  16. SINGH S, Darawshy F, Erlandson K, Narayana JK, et al
    Lower Airway Dysbiosis in NTM+ Bronchiectasis is Associated with NET-Predominant Severe Phenotypes.
    Am J Respir Crit Care Med. 2026 Feb 4:aamag015. doi: 10.1093.
    >> Share

    January 2026
  17. NIMMO C, Perumal R, O'Donnell M
    Tracking wildfire-documenting the spread of bedaquiline-resistant tuberculosis.
    Am J Respir Crit Care Med. 2026;212:19-21.
    >> Share

    December 2025
  18. XIAO K, Cao Y, Yan P, Hu Y, et al
    A Large-Scale Single-Cell Atlas Reveals the Peripheral Immune Panorama of Bacterial Pneumonia.
    Am J Respir Crit Care Med. 2025;211:2363-2381.
    >> Share

    November 2025
  19. PARK K, Kim H, Huh HJ, Namkoong H, et al
    Novel Genetic Loci for Nontuberculous Mycobacterial Pulmonary Disease and Potential Protective Effect of Body Mass Index.
    Am J Respir Crit Care Med. 2025;211:2191-2202.
    >> Share

    October 2025
  20. ALFFENAAR JC
    Isoniazid for Preventive Treatment among Contacts of Multidrug-Resistant Tuberculosis; Does It Make Sense?
    Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202509-2319.
    >> Share

  21. YANG X, Tao S, Jin C
    Advancing Tuberculosis Care through Evidence-based Short-Course Regimens.
    Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202507-1750.
    >> Share

    September 2025
  22. SOBOL R, Omar SV, Brown T, Joseph L, et al
    Transmission of Bedaquiline-resistant Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Am J Respir Crit Care Med. 2025 Sep 30. doi: 10.1164/rccm.202506-1489.
    >> Share

  23. ORTEGA VE, Pienaar E, Escalante P
    Genetic Susceptibility to Non-Tuberculous Mycobacterial Pulmonary Disease, Is the Chicken or the Egg?
    Am J Respir Crit Care Med. 2025 Sep 25. doi: 10.1164/rccm.202508-1970.
    >> Share

  24. LOADER MI, Vasquez Alves SE, Vasquez Alves NL, Coronel J, et al
    IgE, Matrix Metalloproteinases, and Tuberculosis: Immunologic Consequences of Helminth Co-Infection.
    Am J Respir Crit Care Med. 2025 Sep 23. doi: 10.1164/rccm.202507-1710.
    >> Share

  25. MARTINEZ L, Campbell JI, Linde L, Boulahbal F, et al
    The Effectiveness of Isoniazid Preventive Treatment among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis.
    Am J Respir Crit Care Med. 2025 Sep 23. doi: 10.1164/rccm.202411-2340.
    >> Share

  26. MENDELSOHN SC, Jackson GT, Wessels E, Beyers E, et al
    Oral Rinse versus Facemask Capture for Non-Sputum Diagnosis of Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2025 Sep 12. doi: 10.1164/rccm.202506-1477.
    >> Share

  27. GORDHAN BG, Sewcharran A, Waja Z, Martinson N, et al
    Oral Rinse as an Alternative Diagnostic Specimen for Detection of Tuberculosis.
    Am J Respir Crit Care Med. 2025 Sep 12. doi: 10.1164/rccm.202503-0723.
    >> Share

    July 2025
  28. TRAUTH J, Laspoulas A, Dakischew O, Gentil K, et al
    Bedaquiline-Pretomanid-Linezolid as a Bridging Therapy for Adverse Events in Drug-Sensitive Tuberculosis.
    Am J Respir Crit Care Med. 2025 Jul 18. doi: 10.1164/rccm.202501-0150.
    >> Share

  29. HULL RC, Stobo J, Abo-Leyah H, Richardson H, et al
    Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomised, Double-Blind, Placebo-controlled, Phase III Trials (ORBIT 3 and ORBIT 4).
    Am J Respir Crit Care Med. 2025 Jul 15. doi: 10.1164/rccm.202501-0159.
    >> Share

  30. MASIAS-LEON Y, Ruiz-Gonzalez CE, Nino-Meza OJ, Singh M, et al
    Dynamic (11)C-Para-Aminobenzoic Acid Positron Emission Tomography/Computed Tomography for Visualizing Pulmonary Mycobacteroides abscessus Infections.
    Am J Respir Crit Care Med. 2025;211:1253-1263.
    >> Share

  31. PHILLIPS PPJ, Peloquin CA, Sterling TR, Kaur P, et al
    Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial.
    Am J Respir Crit Care Med. 2025;211:1277-1287.
    >> Share

    June 2025
  32. SAUKKONEN J, Munsiff S, Winston C, Duarte R, et al
    Reply to Wilson et al.: The 4-Month HPMZ Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis - A Word of Caution.
    Am J Respir Crit Care Med. 2025.
    >> Share

  33. WILSON JW, Temesgen Z MD, Gaensbauer JG
    The 4-Month HPMZ Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis - A Word of Caution.
    Am J Respir Crit Care Med. 2025.
    >> Share

  34. XIA Y, Jiang W, Zhu X, Pan B, et al
    Global, Regional, and National Burden of Pulmonary Fungal Infections 1990-2021.
    Am J Respir Crit Care Med. 2025;211:1007-1017.
    >> Share

  35. MENZIES NA, Marks SM, Hsieh YL, Swartwood NA, et al
    Contribution of Posttuberculosis Sequelae to Life-Years Lost from Tuberculosis Disease in the United States, 2015-2019.
    Am J Respir Crit Care Med. 2025;211:1059-1068.
    >> Share

    May 2025
  36. THOMSON RM, Wheeler N, Stockwell RE, Bryant J, et al
    Infection by Clonally Related Mycobacterium abscessus Isolates: The Role of Drinking Water.
    Am J Respir Crit Care Med. 2025;211:842-853.
    >> Share

    March 2025
  37. JANSSEN S, Upton C, de Jager VR, van Niekerk C, et al
    Telacebec, A Potent Agent in the Fight Against Tuberculosis: Findings from A Randomized, Phase 2 Clinical Trial and Beyond.
    Am J Respir Crit Care Med. 2025 Mar 21. doi: 10.1164/rccm.202408-1632.
    >> Share

    February 2025
  38. RUMPF CH, Janssen T, Hait RJ, Romme K, et al
    Mucoid Staphylococcus aureus - Prevalence and Association with Lung Function in People with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2025 Feb 7. doi: 10.1164/rccm.202407-1474.
    >> Share

    January 2025
  39. SAUKKONEN JJ, Duarte R, Munsiff SS, Winston CA, et al
    Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2025;211:15-33.
    >> Share

    December 2024
  40. DERENDINGER B, Mochizuki TK, Marcelo D, Shankar D, et al
    C-reactive Protein-based Screening of People with Tuberculosis Symptoms: A Diagnostic Accuracy Study.
    Am J Respir Crit Care Med. 2024 Dec 6. doi: 10.1164/rccm.202405-1000.
    >> Share

    November 2024
  41. EPELBAUM O, Marinelli T, Haydour QS, Pennington KM, et al
    Treatment of Invasive Pulmonary Aspergillosis and Preventive and Empirical Therapy for Invasive Candidiasis in Adult Pulmonary and Critical Care Patients. An Of fi cial American Thoracic Society Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2024 Nov 18. doi: 10.1164/rccm.202410-2045.
    >> Share


  42. Erratum: Who Transmits Tuberculosis to Whom: A Cross-Sectional Analysis of a Cohort Study in Lima, Peru.
    Am J Respir Crit Care Med. 2024;210:1280.
    >> Share

    September 2024
  43. LORE NI, Gramegna A, de Pretis S, Di Marco F, et al
    Single-Cell RNA Sequencing Shows that Circulating Monocytes Enriched in IFN Signaling Are Associated with Nontuberculous Mycobacteria Pulmonary Disease in Cystic Fibrosis.
    Am J Respir Crit Care Med. 2024;210:834-837.
    >> Share

    August 2024
  44. MORGAN SJ, Nichols DP, Ni W, Hong G, et al
    Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis.
    Am J Respir Crit Care Med. 2024 Aug 27. doi: 10.1164/rccm.202406-1128.
    >> Share

  45. ZAVALA S, Stout JE
    A Balancing Act: Finding the Right Dose of Pyrazinamide to Treat Tuberculosis.
    Am J Respir Crit Care Med. 2024 Aug 22. doi: 10.1164/rccm.202406-1262.
    >> Share

  46. AULD SC, Barczak AK, Bishai W, Coussens AK, et al
    Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the 2(nd) International Post-Tuberculosis Symposium.
    Am J Respir Crit Care Med. 2024 Aug 14. doi: 10.1164/rccm.202402-0374.
    >> Share

  47. ROCHE SM, Ottewill C, Mulpeter R, Brown K, et al
    Delayed Tuberculosis Paradoxical Reaction Associated with TNF Inhibitors.
    Am J Respir Crit Care Med. 2024 Aug 12. doi: 10.1164/rccm.202402-0464.
    >> Share

    July 2024
  48. COHEN T, Colijn C, Warren JL
    Approaches for M. tuberculosis Transmission Inference Based on Genomic Data.
    Am J Respir Crit Care Med. 2024 Jul 17. doi: 10.1164/rccm.202404-0835.
    >> Share

  49. LEE WC
    Pairs or Paradoxes: Questioning Assumptions in Tuberculosis Transmission Research.
    Am J Respir Crit Care Med. 2024 Jul 17. doi: 10.1164/rccm.202405-0958.
    >> Share

  50. XU AY, Velasquez GE, Zhang N, Chang VK, et al
    Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized, Controlled Clinical Trial.
    Am J Respir Crit Care Med. 2024 Jul 16. doi: 10.1164/rccm.202401-0165.
    >> Share

  51. MOSSOP M, Ish-Horowicz J, Hughes D, Dobra R, et al
    Chronicity Counts: The Impact of Pseudomonas aeruginosa, Staphylococcus aureus, and Coinfection in Cystic Fibrosis.
    Am J Respir Crit Care Med. 2024;210:240-242.
    >> Share

    June 2024
  52. CRABBE A
    Intracellular Pseudomonas aeruginosa: An Overlooked Reservoir in the Lungs of People with Cystic Fibrosis?
    Am J Respir Crit Care Med. 2024;209:1421-1423.
    >> Share

  53. MALET K, Faure E, Adam D, Donner J, et al
    Intracellular Pseudomonas aeruginosa within the Airway Epithelium of Cystic Fibrosis Lung Tissues.
    Am J Respir Crit Care Med. 2024;209:1453-1462.
    >> Share

  54. FEYS S, Cardinali-Benigni M, Lauwers HM, Jacobs C, et al
    Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis.
    Am J Respir Crit Care Med. 2024 Jun 12. doi: 10.1164/rccm.202401-0145.
    >> Share

    May 2024
  55. ZHANG M, Yang C, Guo Y
    Aspergilloma in Cavity.
    Am J Respir Crit Care Med. 2024 May 31. doi: 10.1164/rccm.202312-2348.
    >> Share

  56. CRABBE A
    Moving Beyond Antibiotics: Exploring the Potential of an Anti-Virulence Monoclonal Antibody Against Pseudomonas aeruginosa in Bronchiectasis.
    Am J Respir Crit Care Med. 2024 May 23. doi: 10.1164/rccm.202405-0974.
    >> Share

  57. LONG MB, Gilmour A, Kehl M, Tabor D, et al
    A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis.
    Am J Respir Crit Care Med. 2024 May 16. doi: 10.1164/rccm.202308-1403.
    >> Share

  58. MARTINEZ-GARCIA MA
    The Heterogeneous World of Non-Tuberculous Mycobacteria in Bronchiectasis.
    Am J Respir Crit Care Med. 2024 May 15. doi: 10.1164/rccm.202405-0936.
    >> Share

  59. GILMORE A, Ortiz J
    Pneumococcal Vaccines.
    Am J Respir Crit Care Med. 2024;209:P5-P7.
    >> Share

  60. LI L, Henkle E, Youngquist BM, Seo S, et al
    Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection.
    Am J Respir Crit Care Med. 2024;209:1246-1254.
    >> Share

  61. MCSHANE PJ, Brunton AE, Choate R, Marmor M, et al
    The Impact of Tobacco Smoking in Bronchiectasis: Data from the United States Bronchiectasis and NTM Research Registry.
    Am J Respir Crit Care Med. 2024 May 7. doi: 10.1164/rccm.202402-0466.
    >> Share

  62. DAVIES GR
    Reconsidering the Role of Isoniazid in Drug-resistant Tuberculosis.
    Am J Respir Crit Care Med. 2024 May 1. doi: 10.1164/rccm.202403-0628.
    >> Share

    April 2024
  63. MATHEMA B, Burzynski J
    One Half of the Pair: Prioritizing Tuberculosis Transmitters for Early Detection.
    Am J Respir Crit Care Med. 2024 Apr 30. doi: 10.1164/rccm.202404-0699.
    >> Share

  64. AKSAMIT TR, Locantore N, Addrizzo-Harris D, Ali J, et al
    Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients.
    Am J Respir Crit Care Med. 2024 Apr 26. doi: 10.1164/rccm.202307-1165.
    >> Share

  65. DRAIN PK
    Another Step Closer to Genomic-informed Therapeutic Dosing for Tuberculosis Drugs.
    Am J Respir Crit Care Med. 2024 Apr 22. doi: 10.1164/rccm.202403-0566.
    >> Share

  66. GAUSI K, Ignatius EH, De Jager V, Upton C, et al
    High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial.
    Am J Respir Crit Care Med. 2024 Apr 2. doi: 10.1164/rccm.202311-2004.
    >> Share

  67. ZHANG M, Luo Q, Li X, Mu X, et al
    Pulmonary Artery Pseudoaneurysm Caused by Pulmonary Mucormycosis.
    Am J Respir Crit Care Med. 2024;209:879-880.
    >> Share

    March 2024
  68. AHMAD S, Wrennall JA, Goriounova AS, Sekhri M, et al
    Specific Inhibition of Orai1-mediated Calcium Signalling Resolves Inflammation and Clears Bacteria in an Acute Respiratory Distress Syndrome Model.
    Am J Respir Crit Care Med. 2024;209:703-715.
    >> Share

  69. VERMA R, Silva KED, Rockwood N, Wasmann RE, et al
    A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing.
    Am J Respir Crit Care Med. 2024 Mar 5. doi: 10.1164/rccm.202309-1583.
    >> Share

    February 2024
  70. TREVISI L, Brooks MB, Becerra MC, Calderon RI, et al
    Who Transmits Tuberculosis to Whom: A Cross-Sectional Analysis of a Cohort Study in Lima, Peru.
    Am J Respir Crit Care Med. 2024 Feb 28. doi: 10.1164/rccm.202307-1217.
    >> Share

    January 2024
  71. MAC AOGAIN M, Xaverius Ivan F, Jaggi TK, Richardson H, et al
    Airway 'Resistotypes' and Clinical Outcomes in Bronchiectasis.
    Am J Respir Crit Care Med. 2024 Jan 25. doi: 10.1164/rccm.202306-1059.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016